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HeartLife klinieken, Utrecht, The Netherlands 2 AMC Heart Center, Academic Medical Center, Amsterdam, The Netherlands ered to be due to endothelial dysfunction in the early phase of atherosclerosis characterised by intima hyperplasia. This results in inadequate nitrate oxide production by the endothelium on provocative stimuli causing smooth muscle cell contraction of the underlying media [4] . The treatment of coronary artery spasms consists of the administration of vasodilators, such as calcium channel blockers and nitrates, while the use of beta blockers is contra-indicated.
The presence of microvascular disease, which is more prevalent in women, has not comprehensively been studied in clinical practice. In a study of 32,856 patients presenting for their first cardiac catheterisation with suspected ischaemic heart disease, 23.3% of women versus 7.1% of men were found to have normal coronary arteries at angiography [5] . Another study found that among 886 patients who were referred for chest pain and subsequently underwent angiography, non-obstructive coronary arteries was five times more frequently present in women than in men (41% versus 8%) [6] . It is well documented that women in the peri-or postmenopausal period more frequently suffer from anginal complaints in the absence of obstructive CAD [7] . In another study of 99 patients with angina and nonobstructive coronary arteries, the mean age of women at diagnosis was 48.5 years and 61.5% of women were postmenopausal [8] .
Classical risk factors such as smoking, hypertension and dyslipidaemia play an important role in CAD. Individuals with microvascular disease have a higher likelihood of presenting with features of the metabolic syndrome (e. g. hypertension, dyslipidaemia, and insulin resistance) than the general population (30% versus 8%, respectively). In addition, these patients show more frequently endothelium-dependent and -independent cutaneous microvascular dysfunction [9] . Risk factors such as pre-eclampsia, migraine, early menopause, polycystic ovarium syndrome and rheumatic diseases all predispose to disturbed epicardial and microvascular coronary dysfunction.
Evolving knowledge regarding sex differences in coronary heart disease is emerging. Prevalence, symptom manifestation, and pathophysiology of CAD vary between women and men. Cardiovascular mortality is the leading cause of death in women and therefore a better insight into the pathophysiology of CAD is required.
The present study on coronary vasospasm published in this journal is an important contribution to further understand the long-term outcome of this coronary syndrome in non-obstructive CAD [10] . Most of the information on this topic stems from Asian patient populations, while the information in Caucasians is rather scarce, in particular in those presenting with an acute coronary syndrome. Even though the number of patients studied is rather small, it demonstrates the benign clinical outcome under optimal medical therapy and surveillance. In addition, it illustrates the usefulness of acetylcholine provocation testing in this cohort of patients to confirm the diagnosis [https://youtu. be/Jm13PEP20eg].
The number of women presenting to our emergency wards with chest pain not due to obstructive CAD is growing. In a recent study of Ong et al., a total of 921 consecutive patients were evaluated to undergo a diagnostic angiogram that showed non-obstructive CAD. A positive acetylcholine provocation test was noted in 33% of the patients, illustrating the frequent finding of epicardial spasm or microvascular dysfunction as the underlying cause of the clinical presentation. The occurrence of epicardial spasm is similar in men and women, while diffuse or microvascular spasm is four times more frequent in women than in men. Moreover, this study showed that acetylcholine testing is safe to assess coronary vasomotor function [11] . With a clear and reassured diagnosis of coronary vasospasm, appropriate medical therapy can be installed to reduce morbidity and mortality. The present study in this journal, as well as the study of Ong et al., should encourage interventionalists to add the acetylcholine provocation test to their diagnostic armamentarium.
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